Associated Papers
The effect of gene dosage and age at the disease onset on the severity of familial Mediterranean fever.
Polat MC et al.
Postgraduate Medicine, 2025
Cost-saving approach with screening of selected variants in genetic diagnosis in Turkish pediatric familial Mediterranean fever patients: a single center longitudinal study.
Sözeri B et al.
The Turkish Journal of Pediatrics, 2024
Sacroiliitis in familial Mediterranean fever: A rare joint involvement of the disease.
Özçelik E et al.
Journal of Paediatrics and Child Health, 2024
Exploring factors for predicting colchicine responsiveness in children with PFAPA.
Özaslan Z et al.
European Journal of Pediatrics, 2024
Osteopontin as an early predictor of atherosclerosis in attack-free Familial Mediterranean fever patients.
Baspinar O et al.
Medicine, 2023
The role of Mediterranean fever gene variants in patients with periodic fever, aphthous stomatitis, pharyngitis, and adenitis syndrome.
Yildiz M et al.
European Journal of Pediatrics, 2021
Clinical Review: Familial Mediterranean Fever-An Overview of Pathogenesis, Symptoms, Ocular Manifestations, and Treatment.
Petrushkin H et al.
Ocular Immunology and Inflammation, 2016
Novel therapeutics for the treatment of familial Mediterranean fever: from colchicine to biologics.
Grattagliano I et al.
Clinical Pharmacology and Therapeutics, 2014
Familial mediterranean fever: a fascinating model of inherited autoinflammatory disorder.
Portincasa P et al.
European Journal of Clinical Investigation, 2013
Comprehensive analysis of a large-scale screen for MEFV gene mutations: do they truly provide a "heterozygote advantage" in Turkey?
Berdeli A et al.
Genetic Testing and Molecular Biomarkers, 0
Screening of the most common MEFV variants in 416 patients of familial mediterranean fever living in Northwest of Iran.
Gharibi A et al.
Journal of Advanced Pharmaceutical Technology & Research, 0
Select a paper to view details